The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Famvir 500mg film-coated tablets

500 milligram(s) Film-coated tablet

Phoenix LabsPA1113/018/003

Main Information

Trade NameFamvir 500mg film-coated tablets
Active SubstancesFamciclovir
Strength500 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderPhoenix Labs
Licence NumberPA1113/018/003

Group Information

ATC CodeJ05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB09 famciclovir

Status

Authorised/WithdrawnAuthorised
Licence Issued17/05/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back